Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Forrester

Showing results (281-290 of 378) with videos related to

Pageof 38
Sort By:
International Journal of Cardiology|October 26, 2005
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic propertiesMatthew J Price, Chung-Chuan Chou, Malka Frantzen, et al.
Circulation|June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial InvestigatorsL Campeau, D B Hunninghake, G L Knatterud, et al.
Circulation. Cardiovascular Interventions|November 16, 2017
Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryYigal Abramowitz, Sreekanth Vemulapalli, Tarun Chakravarty, et al.
Cancer Research|April 3, 2004
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosisS Perwez Hussain, Paul Amstad, Peijun He, et al.
European Heart Journal|June 11, 2011
Intrinsic cardiac origin of human cardiosphere-derived cellsAnthony J White, Rachel R Smith, Satoshi Matsushita, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosisAnthony J White, Gautam Kedia, James M Mirocha, et al.
Circulation|July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG InvestigatorsG L Knatterud, Y Rosenberg, L Campeau, et al.
Circulation|November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trialC W White, F L Gobel, L Campeau, et al.
American Heart Journal|February 22, 2003
Angiographic changes in saphenous vein grafts are predictors of clinical outcomesGenell L Knatterud, Carl White, Nancy L Geller, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarctionRaj R Makkar, Matthew J Price, Michael Lill, et al.
Pageof 38

Showing results (281-290 of 378) with videos related to

Sort By:
Pageof 38
International Journal of Cardiology|October 26, 2005
Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic propertiesMatthew J Price, Chung-Chuan Chou, Malka Frantzen, et al.
Circulation|June 29, 1999
Aggressive cholesterol lowering delays saphenous vein graft atherosclerosis in women, the elderly, and patients with associated risk factors. NHLBI post coronary artery bypass graft clinical trial. Post CABG Trial InvestigatorsL Campeau, D B Hunninghake, G L Knatterud, et al.
Circulation. Cardiovascular Interventions|November 16, 2017
Clinical Impact of Diabetes Mellitus on Outcomes After Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryYigal Abramowitz, Sreekanth Vemulapalli, Tarun Chakravarty, et al.
Cancer Research|April 3, 2004
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosisS Perwez Hussain, Paul Amstad, Peijun He, et al.
European Heart Journal|June 11, 2011
Intrinsic cardiac origin of human cardiosphere-derived cellsAnthony J White, Rachel R Smith, Satoshi Matsushita, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Comparison of coronary artery bypass surgery and percutaneous drug-eluting stent implantation for treatment of left main coronary artery stenosisAnthony J White, Gautam Kedia, James M Mirocha, et al.
Circulation|July 13, 2000
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG InvestigatorsG L Knatterud, Y Rosenberg, L Campeau, et al.
Circulation|November 28, 2001
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trialC W White, F L Gobel, L Campeau, et al.
American Heart Journal|February 22, 2003
Angiographic changes in saphenous vein grafts are predictors of clinical outcomesGenell L Knatterud, Carl White, Nancy L Geller, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 31, 2005
Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model of myocardial infarctionRaj R Makkar, Matthew J Price, Michael Lill, et al.
Pageof 38